Suchergebnisse - "Xia, Shengli"

PubPharm (60)

1

Transcriptome profiling and bioinformatic analysis of the effect of ganoderic acid T prevents Sendai virus infection

enthalten in: Gene | 2023

von Jiang, L. | Zhang, W. | Zhai, D. | +5

2

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China : Results from two studies

enthalten in: Human vaccines & immunotherapeutics | 2022

von Liu, X. | Park, J. | Xia, S. | +12

3

Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years : A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial

enthalten in: Vaccine | 2022

von Zhang, Y. | Wang, Y. | Jia, C. | +21

4

Immunogenicity and Safety of a Booster Dose of Live Attenuated Varicella Vaccine, and Immune Persistence of a Primary Dose for Children Aged 2 to 6 Years

enthalten in: Vaccines | 2022

von Zhang, Y. | Wang, L. | Wang, Y. | +11

5

Knockdown of lncRNA LINC00662 suppresses malignant behaviour of osteosarcoma cells via competition with miR-30b-3p to regulate ELK1 expression

enthalten in: Journal of orthopaedic surgery and research | 2022

von Wang, B. | Xu, Z. | Wang, X. | +4

6

Immunogenicity and Safety of a Novel 13-Valent Pneumococcal Vaccine in Healthy Chinese Infants and Toddlers

enthalten in: Frontiers in microbiology | 2022

von Zhao, Y. | Li, G. | Xia, S. | +12

7

Neuroimaging Studies of Chronic Prostatitis/Chronic Pelvic Pain Syndrome

enthalten in: Pain research & management | 2022

von Zhao, Y. | Lin, J. | Dong, Y. | +7

8

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children : Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial

enthalten in: Frontiers in immunology | 2022

von Xia, S. | Duan, K. | Zhang, Y. | +35

9

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years : a randomised, double-blind, controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Xia, S. | Zhang, Y. | Wang, Y. | +35

10

Identification of transcription factors and construction of a novel miRNA regulatory network in primary osteoarthritis by integrated analysis

enthalten in: BMC musculoskeletal disorders | 2021

von Jiang, Y. | Shen, Y. | Ding, L. | +2

1
2
3
4
5
6
Nächster »
[6]